The Future of Hypertension Management - Renal Denervation Provides Another Treatment Option

The Future of Hypertension Management - Renal Denervation Provides Another Treatment Option



The Future of Hypertension Management webinar will feature global leaders who will share their expertise in the field of Renal Denervation. Presented in English, the webinar will address key topics in the field, including updates on the latest clinical evidence as well as how to identify potential patient candidates for the procedure.

Learning Objectives:

  • Understand the latest RDN clinical evidence including Pivotal trial results
  • Learn the patient profile for renal denervation
  • Clarify the role of patient preference in hypertension management


12:00 Latest Evidence on Renal DenervationDr Justin Davies
12:20 Audience Questions and Answers
12:30 Identifying the Renal Denervation PatientProf Faisal Sharif
12:50 Audience Questions and Answers


Dr Justin Davies (Chairman)
Dr Justin Davies is a clinical academic and consultant interventional cardiologist at the National Heart and Lung Institute, Imperial College London.

After training at Imperial College, he won a prestigious BHF research fellowship to study arterial haemodynamics. Since then he has continued to work on the development of mathematical algorithms to aid understanding of large artery physiology and to develop new tools to assess arterial disease.

The holder of several patents, he has published widely in the field of hypertension, coronary and large artery physiology and is the winner of many national and international awards. He has several international collaborations, and is the developer of iFR and the co-principal investigator of the ADVISE studies, the DEFINE-FLAIR, ORBITA and DEFINE-PCI studies. Justin also has an interest in renal denervation, and has lead the first-in-man studies to evaluate the safety of this technique to patients with chronic systolic heart failure (REACH studies).


Professor Faisal Sharif
Faisal Sharif is the Professor of Translational Cardiovascular Medicine and Innovation at National University of Ireland Galway and an Interventional Cardiologist at the Saolta Group, Galway University Hospital. He is also an Executive Director of BioInnovate Ireland, a multi disciplinary programme for novel medical device innovation. His research predominantly focuses on medical device innovation and clinical translation of novel medical devices and concepts for cardiovascular diseases.


This webinar is supported by: